Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia
- 1 January 2009
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 20 (7) , 525-527
Abstract
This study was planned to assess the response of anti-D in patients with immune thrombocytopenia (ITP). Twenty adults (8 males: 12 females) with a median age 33.5 years (19–59 years) were included. Nine patients had newly-diagnosed ITP, 6 had persistent ITP and 5 had chronic ITP. The overall response rate was 65%. Patients with newly diagnosed ITP showed response rates of 77% (7/9), persistent ITP had response rates 50% (3/6) and patients with chronic ITP had response rates of 60% (3/5). The median time to response was 3 days (1–11 days). There was no correlation of response with age, sex, severity of bleeding, presenting platelet counts, ABO blood group or prior steroid or IVIG response.Keywords
This publication has 15 references indexed in Scilit:
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Current Options for the Treatment of Idiopathic Thrombocytopenic PurpuraSeminars in Hematology, 2007
- Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpuraHematology, 2007
- Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experienceBlood, 2006
- Severe hemolysis following administration of Rho(D) immune globulin in an ITP patient associated with anti-CBlood, 2006
- Immune Thrombocytopenic PurpuraNew England Journal of Medicine, 2002
- Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?Blood, 2002
- A dose of 75 μg/kg/d of i.v. anti‐D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpuraBritish Journal of Haematology, 2001
- Intravenous Anti-D Treatment for Immune Thrombocytopenic PurpuraBlood, 1998
- Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect [see comments]Blood, 1991